Evidence map›Paper›PMID 38483874›Full record

ArticlePloS one2024

Vitamin D deficiency and the vitamin D receptor (VDR) gene polymorphism rs2228570 (FokI) are associated with an increased susceptibility to hypertension among the Bangladeshi population.

Imrul Kayes Nabil, Zimam Mahmud, Sonia Tamanna, Md Mostafijur Rahman, Gowhar Rashid, Md Sarowar Hossain, Humaira Binte Asad, Mohammad Amjad Kamal, Md Zakir Hossain Howlader

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Imrul Kayes NabilDepartment of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, Bangladesh.
Zimam MahmudDepartment of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, Bangladesh.
Sonia TamannaDepartment of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, Bangladesh.ORCID 0000-0001-6810-4226
Md Mostafijur RahmanDepartment of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, Bangladesh.ORCID 0000-0002-2857-0369
Gowhar RashidDepartment of Medical Laboratory Technology, Amity Medical School, Amity University Haryana, (AUH), Gurugram, India.
Md Sarowar HossainDepartment of Pharmacy, Daffodil International University, Birulia, Bangladesh.
Humaira Binte AsadDepartment of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, Bangladesh.ORCID 0000-0002-3662-2608
Mohammad Amjad KamalDepartment of Pharmacy, Daffodil International University, Birulia, Bangladesh.ORCID 0000-0003-0088-0565
Md Zakir Hossain HowladerDepartment of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, Bangladesh.ORCID 0000-0002-3175-8709
University of Dhaka · BDDaffodil International University · BDKing Abdulaziz University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitamin D receptor (VDR) gene is implicated in hypertension vulnerability due to its role in regulating the renin-angiotensin system (RAS) and blood pressure. In this case-control study, a carefully selected cohort of 111 hypertensive individuals and 100 healthy controls underwent serum analysis using HPLC to measure 25-hydroxy vitamin D levels. Polymorphic variations in the VDR gene were detected and characterized using the PCR-RFLP method. At first, lower 25-hydroxy vitamin D levels were observed in hypertensive individuals compared to controls (p<0.001). The genotype frequency of the VDR gene TaqI showed no significant difference between cases and controls (p>0.05). Similarly, no significant difference was found in the VDR gene BsmI genotype frequency between hypertensive patients and controls (p>0.05). However, a statistically significant distinction was observed in the VDR gene FokI genotype frequency between cases and controls (p<0.01). The odds ratios for FokI genotypes (CC, CT, TT, and CT+TT) were 1.0, 0.590, 1.566, and 0.963, respectively. Furthermore, serum 25-hydroxy vitamin D levels were significantly higher in control subjects compared to hypertensive patients across all genotypes of VDR (p<0.001). Hypertensive patients, excluding those with the FokI VDR gene CC genotype, exhibited significantly higher systolic blood pressure levels compared to the control group (p<0.05). Similarly, hypertensive subjects displayed elevated diastolic blood pressure levels compared to the control group (p<0.001). Overall, the results suggest the presence of a potential inverse correlation between serum 25-hydroxy vitamin D levels and hypertension. The association analysis conducted indicated that there is no significant association between TaqI and bsmI genotypic variants and the risk of developing hypertension. However, it was observed that VDR gene polymorphisms do have a clear association with hypertension susceptibility, as evidenced by the significantly higher occurrence of FokI genotypic variants in hypertensive patients. Our study therefore introduces the possibility of utilizing 25-hydroxy vitamin D deficiency and VDR gene polymorphisms as a biomarker for hypertension.

Indexed as

HypertensionVitamin D DeficiencyCase-Control StudiesGenetic Predisposition to DiseaseGenotypeHumansPolymorphism, GeneticPolymorphism, Single NucleotideReceptors, CalcitriolVitamin DReceptors, CalcitriolVDR protein, humanVitamin D

Identifiers

PMID38483874
PMCPMC10939211
OpenAlexW4392817755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.